• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Pharmaceutical Market
Pharmaceutical News
Pharmaceutical Stocks
  • Pharmaceutical Market
  • Pharmaceutical News
  • Pharmaceutical Stocks
pharmaceutical investing

BioCorRx Announces New Implementation of Recovery Program

Bryan Mc Govern
Oct. 25, 2017 09:20AM PST
Pharmaceutical Investing

BioCorRx announced that Advanced Spine and Pain will implement the BioCorRx Recovery Program in all nine of its locations in the Maryland and Virginia area.

BioCorRx (OTCQB:BICX) announced that Advanced Spine and Pain (ASAP) will implement the BioCorRx Recovery Program in all nine of its locations in the Maryland and Virginia area.
As quoted in the press release:

ASAP is the latest group of centers to implement the BioCorRx Recovery Program, a non-addictive, medication-assisted treatment (MAT) program. The program combines the use of a patient specific naltrexone implant with a proprietary cognitive behavioral therapy (CBT) program specifically tailored for the treatment of alcohol and opioid use disorders, along with one year of peer recovery support and tracking.
Dr. Thomas Raley, Founder of ASAP, commented, “Maryland and Virginia are grossly underserved addiction treatment markets where opioid use disorder continues to rise at an alarming rate. ASAP is happy to offer patients BioCorRx’s innovative drug recovery program, a comprehensive, naltrexone-focused medication-assisted treatment (MAT) program for alcohol, heroin, and other opioid addictions. We believe this cutting-edge and highly effective treatment modality has the potential to save many lives from this current epidemic. We plan to offer this program to those individuals who desire to wean off opioids, buprenorphine, alcohol, and heroin.”

Click here to read the full press release.

Source: www.marketwired.com

pharmaceutical investing biocorrx recovery program
The Conversation (0)

Go Deeper

AI Powered

BioRestorative CEO Lance Alstodt Interviewed on "The Big Biz Show"

A colorful brain illustrating brain on pyschedelics.

Psychedelics Stocks to Watch

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Pharmaceutical Investing Stocks

InMed Pharmaceuticals

InMed Pharmaceuticals (INM)
INM

Cardiol Therapeutics

Cardiol Therapeutics (CRDL:CC)
CRDL:CC

Principal Technologies

Principal Technologies (PTEC:CC)
PTEC:CC
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES